Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetic retinopathy
diabetic retinopathy
FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key
Endpoints
Mon, 10/16/17 - 09:42 am
FDA
Novo Nordisk
diabetes
semaglutide
diabetic retinopathy
How IBM is using deep learning to detect diabetic eye disease
Drug Delivery Business News
Sat, 04/22/17 - 01:01 pm
IBM
diabetes
diabetic retinopathy
deep learning
diagnostics
FDA to Review Eylea for Diabetic Retinopathy
Monthly Prescribing Reference
Mon, 12/1/14 - 10:36 am
FDA
Eylea
diabetic retinopathy
Regeneron
FDA accepts sBLA for Lucentis label expansion
Seeking Alpha
Wed, 10/8/14 - 01:06 pm
FDA
Lucentis
Roche
Genentech
diabetic retinopathy
Genentech Submits sBLA for Diabetic Retinopathy Drug
Drug Discovery and Development
Fri, 08/8/14 - 05:08 pm
Genentech
Roche
diabetic retinopathy
Lucentis
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - Angel Broking
Equity Bulls
Sat, 10/5/13 - 10:26 am
Sun Pharma
Intrexon
wet age-related macular degeneration
age-related macular degeneration
macular
edema
uveitis
diabetic retinopathy
Traders Eying Ampio Pharmaceuticals, With 3 Potential Blockbusters In The Red Zone
Seeking Alpha
Sat, 11/17/12 - 01:59 pm
Ampio Pharmaceuticals
Ampion
Optina
Zertane
premature ejaculation
diabetic retinopathy
anti-inflammatories
Ozone Pharma gets patent for molecule of diabetic retinopathy
Pharmabiz
Sat, 06/25/11 - 11:51 am
Ozone Pharma
diabetic retinopathy
Pages
« first
‹ previous
1
2